Nakhate, Vihang
Lasica, Aleksandra B.
Wen, Patrick Y.
Article History
Accepted: 6 September 2024
First Online: 20 September 2024
Declarations
:
: VN received an honorarium for advisory board service from Servier Pharmaceuticals. ABL has no competing interests to disclose. PYW received research support from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition For Adaptive Research, Kazia, MediciNova, Merck, Novartis, Quadriga, Servier, VBI Vaccines and honoraria for consultation or advisory board from Anheart, Astra Zeneca, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Kintara, Merck, Mundipharma, Novartis, Novocure, Sapience, Servier, Symbio, Tango, Telix, VBI Vaccines.